13.01.2011
- DSM Pharmaceutical Products and Codexis have signed an enzyme supply agreement, the companies announced. The agreement grants DSM rights to use Codexis' custom biocatalysts and...
07.12.2010
- Ian C. Read has been elected Pfizer's president, CEO and director, succeeding Jeffrey Kindler, who is leaving the company. Since 2006, Read has led Pfizer's worldwide...
04.08.2010
- Pfizer is on the lookout for further acquisitions in the area of emerging markets, established products, inflammatory diseases as well as cancer and alzheimer, German daily...
04.08.2010
- Sanofi-Aventis has grabbed the headlines with its $18.4 billion bid for Genzyme, but the French drugmaker may be wiser to stick with smaller, bolt-on acquisitions. Sanofi is trying...
04.08.2010
- Sanofi-Aventis investors have urged the drugmaker not to pay more than about $19 billion to land Genzyme, some $10 a share below the price wanted by the U.S. biotech group. Two...
03.08.2010
- Sanofi-Aventis chief executive Chris Viehbacher should aim to land U.S. biotech group Genzyme for around$19 billion to keep his investors on side, according to institutional...
02.08.2010
- Chances are, every big pharmaceutical company is running the numbers and weighing the pros and cons of acquiring Genzyme. French drugmaker Sanofi-Aventis is poised to make a bid...
30.06.2010
- The Supreme Court said on Tuesday that it rejected an appeal by Pfizer on a ruling that reinstated U.S. lawsuits by Nigerian families, who say the drugmaker tested an experimental...
